URSOFERRAN
LIVE

Serial Number

79300278

Owner

Serum-Werk Bernburg AG

Attorney

Rachel Jacques

Filing Date

Nov 11, 2020

Add to watchlist:

No watchlists yet
View on USPTO

URSOFERRAN Trademark

Serial Number: 79300278 • Registration: 6504674

URSOFERRAN is a trademark filed by Serum-Werk Bernburg AG on November 11, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Serum-Werk Bernburg AG

Hallesche Landstrasse 105 b

Entity Type: 09

Trademark Details

Filing Date

November 11, 2020

Registration Date

October 5, 2021

Published for Opposition

July 20, 2021

Goods & Services

Human and veterinary pharmaceutical preparations for the prevention or treatment of iron deficiency diseases

Filing History

INTERNATIONAL REGISTRATION RENEWED
Oct 19, 2023 RNWL
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 10, 2022 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Mar 24, 2022 FICS
FINAL DISPOSITION PROCESSED
Mar 24, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 5, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 5, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 20, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jul 20, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 30, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 16, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 16, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 16, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 16, 2021 TROA
REFUSAL PROCESSED BY IB
May 30, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 8, 2021 RFCS
REFUSAL PROCESSED BY MPU
May 6, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 4, 2021 RFCR
NON-FINAL ACTION WRITTEN
May 3, 2021 CNRT
ASSIGNED TO EXAMINER
Apr 21, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 22, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 18, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 18, 2020 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Dec 17, 2020 SDRC